×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| VIMTA LABS LTD. | 911.48 | 214.96 | 899.23 | 7.79 | 2,104 | 34.6 |
| NOVARTIS INDIA LTD. | 1,036.00 | 254.50 | 930.00 | 10.31 | 2064 | 23.9 |
| SOLARA ACTIVE PHARMA SCIENCES | 3018 | 80.9 | 3003.1 | 2.03 | 2053 |
Vimta Labs Ltd., with Security Code 524394, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78.6 | 79.1 | 76.4 | 80.8 | 82.1 | 72.2 | 80.0 | 78.3 | 80.1 | 83.1 |
| Expenses | 54.8 | 54.0 | 55.5 | 57.2 | 58.4 | 57.0 | 59.2 | 54.7 | 56.6 | 54.2 |
| Operating Profit | 23.8 | 25.1 | 21.0 | 23.6 | 23.8 | 15.3 | 20.9 | 23.6 | 23.6 | 28.9 |
| OPM % | 30.31% | 31.75% | 27.48% | 29.16% | 29% | 21.17% | 26.07% | 30.16% | 29.43% | 34.81% |
| Other Income | 0.9 | 0.8 | 1.1 | 0.7 | 0.6 | 2.0 | 0.9 | 0.5 | 0.7 | 0.7 |
| Interest | 0.9 | 0.8 | 0.7 | 0.2 | 0.4 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 |
| Depreciation | 7.2 | 7.5 | 7.8 | 8.0 | 8.5 | 8.9 | 8.6 | 8.0 | 8.1 | 8.2 |
| Profit before tax | 16.6 | 17.6 | 13.7 | 16.0 | 15.5 | 7.8 | 12.6 | 15.6 | 15.7 | 21.0 |
| Tax % | 27.5% | 25.6% | 27.3% | 23.3% | 25.2% | 24.5% | 24.9% | 24.1% | 25.7% | 22.1% |
| Net Profit | 12.0 | 13.1 | 10.0 | 12.3 | 11.6 | 5.9 | 9.5 | 11.8 | 11.6 | 14.6 |
| EPS in Rs | 5.33 | 5.8 | 4.39 | 5.45 | 5.15 | 2.65 | 4.2 | 5.26 | 5.18 | 6.47 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 79.9 | 77.4 | 81.8 | 83.5 | 73.4 | 81.7 | 79.7 | 81.8 | 84.7 | 89.9 |
| Expenses | 54.5 | 55.9 | 57.6 | 58.8 | 57.5 | 59.8 | 55.3 | 57.2 | 54.8 | 56.8 |
| Operating Profit | 25.4 | 21.5 | 24.2 | 24.6 | 15.9 | 21.8 | 24.4 | 24.5 | 29.9 | 33.1 |
| OPM % | 31.8% | 27.7% | 29.6% | 29.5% | 21.6% | 26.7% | 30.6% | 30% | 35.3% | 36.8% |
| Other Income | 0.8 | 1.1 | 0.7 | 0.6 | 2.0 | 0.9 | 0.5 | 0.7 | 0.7 | 1.2 |
| Interest | 0.8 | 0.7 | 0.2 | 0.4 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.6 |
| Depreciation | 7.6 | 7.8 | 8.0 | 8.5 | 8.9 | 8.7 | 8.1 | 8.2 | 8.3 | 9.8 |
| Profit before tax | 17.8 | 14.1 | 16.6 | 16.3 | 8.4 | 13.5 | 16.3 | 16.5 | 21.9 | 23.9 |
| Tax % | 25.6% | 27.3% | 23.4% | 25.2% | 24.6% | 25% | 24.2% | 25.7% | 22.3% | 26.8% |
| Net Profit | 13.2 | 10.2 | 12.7 | 12.2 | 6.3 | 10.1 | 12.4 | 12.3 | 15.2 | 21.5 |
| EPS in Rs | 5 | 4 | 5 | 5 | 2 | 4 | 5 | 5 | 6 | 9 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 8% |
| 3 Years: | 14% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 22% |
| TTM: | 35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 57% |
| 3 Years: | 41% |
| 1 Year: | 93% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 15% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 24% |
| TTM: | 34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 57% |
| 3 Years: | 41% |
| 1 Year: | 93% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|